Medscape September 18, 2024
MADRID — The use of continuous glucose monitoring (CGM) reduced the risk for hospitalization and improved glucose control in people with type 2 diabetes, regardless of insulin use, a new analysis of real-world data found.
The data were presented at the European Association for the Study of Diabetes (EASD) 2024 Annual Meeting and simultaneously published in Diabetes, Obesity and Metabolism. The data on hospitalizations and A1c lowering were presented separately at EASD by two of the study investigators, Satish K. Garg, MD, professor of medicine and director of the Adult Diabetes Program at the Barbara Davis Center, University of Colorado, Aurora, Colorado, and Richard M. Bergenstal, MD, executive director of the International Diabetes Center of HealthPartners Institute, Minneapolis.
The advantages...
Today's Sponsors
Today's Sponsor